WTX-124 initial Phase 1b expansion arm data showed 30% overall response rate as a monotherapy in a defined subset of post-ICI advanced or metastatic cutaneous melanoma patients, with potential best-in ...

A wide-ranging look at werewolf folklore, global shapeshifter myths, medical explanations, and the cultural history behind it ...

Werewolf Therapeutics (HOWL) announced a pipeline update, including a review of recent data for its INDUKINE programs, and a business overview of ...

IFLScience needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time.